Myostatin negatively regulates satellite cell activation and self-renewal by McCroskery, Seumas et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 

 
 The Rockefeller University Press, 0021-9525/2003/09/1135/13 $8.00
The Journal of Cell Biology, Volume 162, Number 6, September 15, 2003 1135–1147
http://www.jcb.org/cgi/doi/10.1083/jcb.200207056
 
JCB
 
Article
 
1135
 
Myostatin negatively regulates satellite cell activation 
and self-renewal
 
Seumas McCroskery,
 
1,2
 
 Mark Thomas,
 
1
 
 Linda Maxwell,
 
2
 
 Mridula Sharma,
 
1
 
 and Ravi Kambadur
 
1
 
1
 
Animal Genomics, AgResearch, Hamilton 2015, New Zealand
 
2
 
Department of Pathology, University of Auckland, Auckland 1020, New Zealand
 
atellite cells are quiescent muscle stem cells that
promote postnatal muscle growth and repair. Here
we show that 
 
myostatin
 
, a TGF-
 
 
 
 member, signals
satellite cell quiescence and also negatively regulates
satellite cell self-renewal. BrdU labeling in vivo revealed
that, among the Myostatin-deﬁcient satellite cells, higher
numbers of satellite cells are activated as compared with
wild type. In contrast, addition of Myostatin to myoﬁber
explant cultures inhibits satellite cell activation. Cell cycle
analysis conﬁrms that Myostatin up-regulated p21, a Cdk
inhibitor, and decreased the levels and activity of Cdk2
protein in satellite cells. Hence, Myostatin negatively
S
 
regulates the G
 
1
 
 to S progression and thus maintains the
quiescent status of satellite cells. Immunohistochemical
analysis with CD34 antibodies indicates that there is an
increased number of satellite cells per unit length of
freshly isolated Mstn
 
 
 
/
 
 
 
 muscle ﬁbers. Determination of
proliferation rate suggests that this elevation in satellite
cell number could be due to increased self-renewal and
delayed expression of the differentiation gene (
 
myogenin
 
)
in Mstn
 
 
 
/
 
 
 
 adult myoblasts. Taken together, these results
suggest that Myostatin is a potent negative regulator of
satellite cell activation and thus signals the quiescence of
satellite cells.
 
Introduction
 
Muscle satellite cells are a distinct lineage of myogenic
progenitors responsible for postnatal muscle growth. Satellite
cells are mitotically quiescent and are known to express several
myogenic markers. When stimulated by damage to the muscle,
satellite cells are activated to reenter the cell cycle and express
myogenic regulatory factors. The resulting myoblasts subse-
quently differentiate and fuse to form new replacement
myofibers (Bischoff, 1989). The total number of quiescent
satellite cells remains constant over repeated cycles of de-
generation and regeneration, suggesting that the steady-
state satellite cell population is maintained by self-renewal
(Yoshida et al., 1998; Schmalbruch and Lewis, 2000; Hes-
lop et al., 2001).
Several different growth factors, including HGFs (Maina
et al., 1996) and FGFs (Flanagan-Steet et al., 2000), have
been shown to affect the postnatal muscle growth by regulating
satellite cell activation. Nowhere is the influence of growth
factors on skeletal muscle development more dramatically
demonstrated than by the remarkable widespread skeletal
muscle mass of 
 
myostatin
 
-deficient animals (Kambadur et al.,
1997; McPherron and Lee, 1997; McPherron et al., 1997).
Myostatin is a secreted growth and differentiation factor
(GDF-8) that belongs to the TGF-
 
 
 
 superfamily and shares
several features with other members. The 
 
myostatin
 
-null
mice and cattle with mutation in 
 
myostatin
 
 showed increased
muscling due to generalized hyperplasia and, to a lesser extent,
hypertrophy of muscle. The phenotype of 
 
myostatin
 
 mutant
cattle and mice has clearly established that Myostatin negatively
regulates muscle growth. Consistent with this, work from our
laboratory as well as other published results suggest that
Myostatin inhibits myoblast proliferation (Thomas et al.,
2000; Zhu et al., 2000; Taylor et al., 2001). Investigations
into mechanisms revealed that one of the targets of Myostatin
signaling is the cell cycle. In cell culture studies, Myostatin
inhibited the progression of myoblasts at G
 
1
 
 and G
 
2
 
 phases
of the cell cycle. This cell cycle arrest was shown to be
mediated through p21, which was the only Cdk inhibitor
to be up-regulated by Myostatin. In addition, Myostatin
treatment also specifically reduced levels of Cdk2, the
combination of which resulted in markedly reduced activity
of Cdk2. This, in turn, led to the hypophosphorylation of
retinoblastoma protein and thus inhibition of progression
into S phase of the cell cycle (Thomas et al., 2000).
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Several studies have implicated a role for Myostatin post-
natally in muscle misuse and wasting. Serum concentrations
of Myostatin have been reported to be increased in HIV-
infected men with weight loss, suggesting that increased
Myostatin levels may contribute to the pathophysiology of
muscle wasting during HIV infection (Gonzalez-Cadavid et
al., 1998). Similarly, a study by Wehling et al. (2000) and
Carlson et al. (1999) indicated that atrophy-related muscle
loss due to hind limb suspension in mice was associated with
increased Myostatin levels in m. plantaris. One of the expla-
nations for the elevated levels of Myostatin in hind limb un-
loading is that Myostatin may function as an inhibitor of
satellite cell proliferation. Indeed, this is supported by the
fact that 
 
myostatin
 
-null mice display muscle hypertrophy
and increased postnatal muscle growth, both of which have
been related to increased satellite cell activity (Grounds and
Yablonka-Reuveni, 1993; Mesires and Doumit, 2002). This
circumstantial evidence led us to speculate that Myostatin
may have a role in postnatal muscle growth by controlling
the satellite cell quiescence. Here we report that Myostatin is
expressed in satellite cells and that lack of 
 
myostatin
 
 in mice
leads to increased number of satellite cells per unit length of
muscle fiber. We also show that in 
 
myostatin
 
-null mice, a
higher percentage of the satellite cells are in an activated
Figure 1. Myostatin is expressed in satellite cells. M. tibialis anterior was serially sectioned and immunostained with antibodies specific for 
(A) Myostatin and (B) Pax7. The myonuclei were stained with DAPI. The same muscle was used for in situ and probed for Myostatin (C) and 
Pax7 transcripts (D). Arrows indicate the stained satellite cells, and DAPI-stained myonuclei are also shown in the insets (B and D). (E) Micrograph 
showing in situ hybridization performed with myostatin antisense probe on muscle sections of myostatin-null mouse. (F, i) Agarose gel 
electrophoresis of RT-PCR products derived from satellite cell total RNA. Primers specific for 3  region of myostatin amplify the expected 
515-bp product in a combined RT-PCR reaction (Mstn). Amplicons are not detected in the absence of template (Negative control). Pax7 was 
amplified with primers designed to produce a 571-bp product (Pax7), and CD34 splice variants were also PCR amplified from the same RT 
reaction (CD34 splice variants). 1-kb plus DNA ladder is shown. (F, ii) Western blot showing the presence of the full-length 52-kD Myostatin 
protein in satellite cell protein extract. Bars, 10  m.T
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state as compared with wild-type mice. Therefore, the ob-
served hypertrophy phenotype and increased postnatal mus-
cle growth in 
 
myostatin
 
-null mice could be due to increased
number and activation of satellite cells.
 
Results
 
Myostatin is expressed in satellite cells and in the 
adult myoblasts
 
To assess if Myostatin is present in satellite cells, we per-
formed immunocytochemistry and in situ hybridizations on
serial cross sections of m. tibialis anterior. Satellite cells on
fibers were identified by positive immunostaining with anti-
Pax7 antibodies (Fig. 1 B). In the serial sections, the Pax7-
positive satellite cells were also positive for Myostatin immu-
nostaining (Fig. 1 A). Similarly, in situ hybridization studies
with myostatin and Pax7 digoxigenin-labeled probes re-
vealed that Pax7-positive satellite cells (Fig. 1 D) also express
abundant levels of myostatin mRNA (Fig. 1 C). Expression
of myostatin mRNA is not detected in the muscle sections
derived from 
 
myostatin
 
 knockout mice, confirming the spec-
ificity of the myostatin probe (Fig. 1 E). Therefore, it is con-
vincing that the satellite cells attached to the muscle fibers
express Myostatin. To further prove that myostatin is
present in satellite cells, RT-PCR and Western blot analysis
were performed on the total RNA and protein extracts, re-
spectively, of quiescent satellite cells isolated by Percoll gra-
dient. The PCR primers designed to specifically amplify the
processed portion of 
 
myostatin
 
 do indeed amplify the ex-
pected 515-bp product from the cDNA pool derived from
satellite cell RNA (Fig. 1 F, i). Furthermore, anti-Myostatin
antibodies specifically recognized the full-length Myostatin
in the protein extracts, confirming that the satellite cells do
express Myostatin (Fig. 1 F, ii). To demonstrate that the
cells isolated by Percoll gradient techniques are indeed satel-
lite cells, independent PCR reactions were performed with
Pax7 and CD34 primers (satellite cell–specific markers).
The results show that RT reactions indeed contained Pax7
and CD34 splice variant cDNAs (Fig. 1 F, i). 
To gain insight into the role of Myostatin in satellite cell
activation and proliferation, low passage number primary
cultures were isolated from hind limb muscles of 8-wk-old
 
myostatin
 
-null and wild-type mice to generate highly puri-
fied satellite cell–derived cultures and preclude the inclusion
of neonatal myoblasts (see Materials and methods). Previous
work has demonstrated that proliferating primary adult
myoblasts derived from satellite cells express myoblast mark-
ers such as MyoD, Desmin, and adhesion molecules, but not
terminal differentiation markers such as Myogenin or Myo-
sin heavy chain. Therefore, to characterize the cultures used
in this experiment, we immunostained the adult myoblast
cultures with MyoD- and M-cadherin–specific antibodies.
Over 95% of proliferating primary cells derived from the
hind limb muscles of wild-type and 
 
myostatin
 
 knockout
mice expressed M-cadherin and MyoD, indicating that the
isolation procedure generated highly purified cultures of
myogenic cells from both wild-type and 
 
myostatin
 
 knockout
mice (Fig. 2, A and B). Proliferating myogenic precursor
cells in vivo, and myoblasts in vitro, express the intermediate
filament Desmin, whereas, satellite cells do not express
Desmin (George-Weinstein et al., 1993). Hence, primary
cultures were immunostained with antibodies reactive with
Desmin to assess their developmental status. As shown in
Fig. 2 C, uniform expression of Desmin is detected, indicat-
Figure 2. Immunocytochemistry of isolated satellite cells. Adult 
myoblasts were cultured from the hind leg muscles of either wild-type 
or Mstn
 / mice, fixed, and immunostained for M-cadherin (A), 
MyoD (B), Desmin (C), and CD34 (D). DAPI staining of the nuclei in 
the corresponding fields is also shown; panel E shows the background 
immunofluorescence when anti–mouse secondary antibody was 
used in the absence of primary antibody. Similar background was 
observed for all other secondary antibody negative controls. Greater 
than 95% of the isolated cultured cells were myogenic.T
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ing that the primary cultures are all activated myogenic pre-
cursor cells. It has been recently demonstrated that expres-
sion of CD34 protein is associated with skeletal muscle
precursors but not with the differentiated fibers. To rule out
any myogenic differentiation during the isolation procedure
of primary cultures, the cells were immunostained with anti-
CD34 antibodies. As shown in Fig. 2 D, almost all of the
cultured cells were immunopositive for CD34, indicating
that under the culturing conditions, the myogenic precursor
cells are in active proliferation status (Beauchamp et al.,
2000). The negative control did not show any nonspecific
background (Fig. 2 E).
Three independent techniques, RT-PCR, Western blot-
ting, and immunocytochemistry, were used to ascertain the
expression of 
 
myostatin
 
 in adult myoblasts. As shown in Fig.
3 A, the PCR reaction amplified the expected size fragment
of 1.2-kb myostatin ORF. In addition, anti-Myostatin anti-
bodies specifically recognized Myostatin on the Western
blot performed on the protein extracts derived from the
adult myoblasts (Fig. 3 B). To further confirm the expres-
sion of Myostatin, primary cultures were immunostained
with Myostatin antibodies. As shown in Fig. 3 C (i and ii),
virtually all the cultured myoblasts showed staining with
Myostatin antibodies. Thus, it is clear from these results that
Myostatin is expressed in satellite cells and in the adult myo-
blasts derived from satellite cells.
 
Increased activation of satellite cells in the absence of 
Myostatin in vivo
 
Using single-cell PCR analysis, Cornelison and Wold
(1997) have previously speculated that Myostatin is an im-
portant regulator of the quiescent state of satellite cells.
Thus, to determine the involvement of Myostatin in satellite
cell quiescence, the cell cycle phase of the satellite cells at-
tached to myofibers in vivo in wild-type and 
 
myostatin
 
knockout mice was assessed. Both wild-type and 
 
myostatin
 
knockout mice were pulsed with BrdU, and satellite cells
from m. tibialis anterior muscle were isolated by Percoll gra-
Figure 3. Myostatin is expressed in adult myoblasts 
derived from satellite cells. (A) Agarose gel electro-
phoresis of myostatin ORF amplified in a combined 
RT-PCR reaction using total RNA from adult 
myoblasts (lane 2). Amplicons are not detected in 
the absence of template (negative control) (lane 3). 
1-kb plus DNA ladder is shown in lane 1. 
(B) Western analysis from proteins isolated from 
adult myoblasts cultured for 48 h showing both the 
full-length (52 kD) and LAP (38 kD) peptides of 
Myostatin. (C) Representative immunofluorescence 
showing the presence of Myostatin in wild-type 
adult myoblasts (i) and absence in myostatin-null 
(Mstn
 / ) myoblasts (iii). DAPI staining of the nuclei 
is shown in the corresponding fields (ii and iv).T
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dient. Characterization of satellite cells with M-cadherin and
CD34 immunostaining revealed that the cultures were
 
 
 
95% pure and that there is no difference in the yield or
purity between wild-type and 
 
myostatin
 
 knockout mice (un-
published data). BrdU-positive satellite cells were identified
by immunostaining. As shown in Fig. 4 A (i), 
 
 
 
18% of sat-
ellite cells isolated from 4-wk-old wild-type mice were la-
beled with BrdU. However, in 
 
myostatin
 
 knockout mice, a
significantly higher number (33%) of satellite cells was acti-
vated to enter S phase. In 8-wk-old wild-type muscle, 8% of
the satellite cells isolated were BrdU positive, whereas in the
 
myostatin
 
-null muscle, 15% of the satellite cells were BrdU
positive. When the same experiment was repeated on older
mice (6 mo old), only 3.2% of the wild-type satellite cells
Figure 4. Lack of Myostatin increases the activation of satellite cells on myofibers. (A, i) In vivo quantification of activated satellite cells in 
the muscle of wild-type and myostatin-null mice. Activated satellite cells were labeled with BrdU in wild-type or myostatin-null (Mstn
  / ) 
mice of 4 wk, 8 wk, or 6 mo and were isolated using Percoll gradient. 5,000–10,000 satellite cells were immunostained for BrdU, and 
percentages of nuclei that were positive for BrdU labeling are shown. **, P   0.01 (as compared with wild type). At least a total of 1,000 cells 
were counted in each of three replicates. The data provided are an average of three animals each. (A, ii) Myostatin inhibits the migration of 
satellite cells from fibers. Single muscle fibers (n   32) were isolated from the muscle and incubated in media conducive to the migration of 
myogenic precursor cells. The addition of Myostatin in increasing concentrations decreases the percentage of fibers with migrated satellite 
cells (**, P   0.01). (B, i) The number of satellite cells (CD34 positive) per 100 myonuclei in wild-type and myostatin-null (Mstn
 / ) myofibers 
is shown. **, P   0.01 (as compared with wild type). More than 1,000 nuclei were counted in each of three replicates. The data presented are 
an average of three animals each. (B, ii) Micrograph showing typical CD34-immunostained satellite cell and (iii) myonuclei were visualized 
by counterstaining with DAPI. (C, i) An increased number of satellite cells migrate from myostatin-null fibers. Quantitative analysis demonstrates 
that an increased number of myogenic progenitor cells migrates from single myofibers isolated from myostatin-null mice as compared with 
wild-type myofibers (*, P   0.05). (C, ii) An example of satellite cells surrounding an isolated myofiber after 72 h.T
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had incorporated BrdU. A threefold higher number, 
 
 
 
10%
of Myostatin-deficient satellite cells, had incorporated BrdU
(Fig. 4 A i), indicating that irrespective of the age, lack of
functional Myostatin results in an increased number of acti-
vated satellite cells in uninjured muscle. To investigate the
role of Myostatin in inhibiting satellite cell activation ex
vivo, recombinant Myostatin was added to single isolated fi-
bers in varying concentrations, and satellite cells were left to
detach from the fiber and migrate to the well. Fig. 4 A (ii)
graphically demonstrates that on average, 80% of the wells
had identifiable satellite cells, which were subsequently dif-
ferentiated in low serum to show they were myogenic. In
comparison, in media containing 1 
 
 
 
g/ml of Myostatin,
only 37% of fibers had migrated myogenic precursor cells in
the well, while media with increased amounts of Myostatin,
2 and 5 
 
 
 
g/ml, had 12 and 0% migrated myogenic cells, re-
spectively. These results confirm that a lack of myostatin ex-
pression leads to increased activation of satellite cells in vivo,
and overexpression of myostatin inhibits activation.
 
Steady-state satellite cell numbers are increased on 
Myostatin-deficient muscle fibers
 
A constant pool of satellite cells is maintained on muscle fi-
bers during repeated cycles of degeneration and regenera-
tion. A portion of myoblasts derived from the activated sat-
ellite cells returns to quiescent status, thus maintaining a
constant number of satellite cells per unit length of muscle
fiber by the self-renewal process. Adult myoblasts derived
from the 
 
myostatin
 
-null mice tend to proliferate faster (see
the results below), suggesting the possibility of increased
self-renewal of the satellite cells in these knockout mice.
Thus, the steady-state number of satellite cells per fiber of
the muscle fibers isolated from both wild-type and 
 
myosta-
tin
 
-null mice was measured. As shown in Fig. 4 B (i), there is
a significantly higher number of steady-state satellite cells
per unit of muscle fiber in 
 
myostatin
 
 knockout mice as com-
pared with the wild-type mice. An example of CD34-posi-
tive satellite cells on the muscle fiber is shown in Fig. 4 B (ii).
To further demonstrate this increase in satellite cell num-
ber per fiber, myofiber explant culture (Fig. 4 C, ii) was used
(Hawke et al., 2003). Results showed that a significantly
higher number of myogenic precursor cells had migrated
from the 
 
myostatin
 
-null fiber (83 
 
 
 
 8; 
 
n
 
 
 
  
 
31) as compared
with the wild type (51 
 
 
 
 6; 
 
n
 
 
 
  
 
31). The difference in total
number of satellite cells between 
 
myostatin
 
-null and wild-
type fibers was significant (P 
 
  
 
0.05) (Fig. 4 C, i).
 
Primary and secondary myoblasts that lack Myostatin 
proliferate faster
 
Previously, we have shown that high concentrations of Myo-
statin inhibit the proliferation of myoblasts by controlling
the G
 
1
 
 to S transition during cell cycle (Thomas et al.,
2000). Thus, here, we determined the proliferation rate and
the doubling time of adult myoblasts isolated from both
wild-type and 
 
myostatin
 
 knockout mice. For this purpose,
we plated secondary myoblasts cultured from embryonic day
(E) 17 and adult myoblasts from postnatal muscle and deter-
mined their proliferation. Primary myoblasts isolated from
wild-type and 
 
myostatin
 
 knockout mice underwent a lag pe-
riod of 3 d before they became proliferative (unpublished
data). Cultured secondary myoblasts, isolated from E17 em-
bryos from 
 
myostatin
 
 knockout mice, proliferated signifi-
cantly faster, resulting in an increase in the number of
Mstn
 
 
 
/
 
 
 
 myoblasts as compared with the wild-type myo-
blasts (Fig. 5 A). The increased proliferation rate of Mstn
 
 
 
/
 
 
 
myoblasts is also reflected by three times higher cumulative
population doublings attained by the 
 
myostatin
 
-null myo-
blasts, compared with the wild-type myoblasts (unpublished
data). In addition, the proliferation rate of adult myoblasts
derived from hind limbs of 4-wk-old 
 
myostatin
 
-null and
wild-type mice were also assayed using the methylene blue
cell proliferation assay. As seen in Fig. 5 B, 
 
myostatin
 
-null
myoblasts proliferate significantly faster than wild-type myo-
blasts after 3 d in culture. The proliferation experiments de-
scribed above were performed on myoblasts derived from
satellite cells that were isolated from mixed muscles that
contain both fast and slow twitch fibers. A recent report,
however, suggests that the satellite cells isolated from fast
and slow fibers are inherently different (Rosenblatt et al.,
1996). Thus, to address the role of Myostatin in the prolifer-
ation of myoblasts from fast or slow fibers, we cultured adult
myoblasts from m. tibialis anterior (fast twitch) or m. soleus
(slow twitch) of both normal and 
 
myostatin
 
 knockout mice.
The proliferation assay again indicates that both fast (Fig. 5
C) and slow (Fig. 5 D) fiber–specific adult myoblasts iso-
lated from 
 
myostatin
 
 knockout mice proliferate much faster
as compared with the wild-type adult myoblasts. Thus, re-
gardless of the origin of satellite cells, lack of 
 
myostatin
 
 ap-
pears to increase the proliferation rate of both fast and slow
fiber–specific satellite cells.
 
Addition of exogenous Myostatin inhibits satellite cell 
activation and myoblast proliferation
 
To show the direct inhibitory effects of Myostatin on myo-
blast proliferation, tissue-dissociated satellite cells were iso-
lated from both wild-type and 
 
myostatin
 
-null mice and used
in a methylene blue assay. The same number of wild-type
and 
 
myostatin
 
-null myoblasts were cultured in the media,
and myostatin was added in increasing concentrations to
only 
 
myostatin-
 
null cultures. After 48 h of proliferation, the
cells were fixed with 10% formal saline and stained with the
methylene blue. When recombinant Myostatin was added to
the media in increasing amounts, the enhanced proliferation
rate seen in the 
 
myostatin
 
-null myoblasts was reduced to that
of the wild-type myoblasts (Fig. 5 E).
 
Cell cycle progression of wild-type and
Myostatin-deficient satellite cells
 
Proliferation assays clearly demonstrate that adult myoblasts
that lack Myostatin proliferate much faster than the wild-
type myoblasts. Furthermore, our previous results with
C
 
2
 
C
 
12
 
 cells indicate that addition of exogenous Myostatin to
the growth medium (GM) arrests the proliferation of C
 
2
 
C12
cells in G1 phase of the cell cycle (Thomas et al., 2000).
Thus, we next asked if the increased proliferation observed
in the myostatin knockout myoblasts is due to deregulated
G1 to S phase transition. FACS
® analysis of the cell cycle dis-
tribution of asynchronous populations of wild-type and myo-
statin knockout adult myoblasts in proliferation media re-
vealed that myostatin knockout myoblasts had a twofoldT
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increase in S phase cell population (Fig. 6 A). To confirm
these results, we then synchronized the adult myoblasts in
G0 phase by growing them in methionine-free media and
initiated S phase entry by serum stimulation. To monitor
the number of cells in S phase, the cells were pulsed with
BrdU, and the percent of labeled cells was determined by
immunostaining the fixed cells at the end of the assay. The
results indicate that within the first hour after serum stimu-
lation, 7% of Mstn
 /  myoblasts entered S phase. In con-
trast, only 2% of wild-type myoblasts were found to be in S
phase. Similarly, an enhanced number of BrdU-positive cells
was observed up to 8 h after serum stimulation in Mstn
 / 
myoblasts (Fig. 6 B). These results indicate that lack of Myo-
statin increases the proliferation of myoblasts by deregulat-
ing the S phase entry.
Given that Myostatin inhibits the G1 to S phase progres-
sion of myoblasts, we speculated that Myostatin may affect
one or more of the cell cycle control proteins. Of particular
interest was the Cdk inhibitor p21, which has previously been
shown to be involved in cell cycle arrest in the G1 phase. In
addition, growth arrest by Myostatin signaling has been
shown to influence p21 expression (Thomas et al., 2000;
Joulia et al., 2003). To examine this possibility, actively grow-
ing adult myoblasts derived from satellite cells were cultured
with or without Myostatin in the media for 24 h before har-
vesting. Western analysis with p21-specific antibodies re-
vealed that Myostatin treatment up-regulated p21 expression
(Fig. 6 C). To determine if the elevated p21 levels seen in
Myostatin-treated myoblasts coincided with constant or down-
regulated Cdk2, and therefore a change in the ratio of p21 to
Cdk2, we performed Western blot analysis for Cdk2. Fig. 6
C shows that the level of Cdk2 was down-regulated in pro-
tein extracts from myoblasts treated with Myostatin.
Delayed differentiation potential of
Myostatin-deficient myoblasts
Myogenic differentiation of myoblasts occurs upon with-
drawal of actively growing myoblasts from cell cycle into G0
and subsequent expression of myogenic markers. As the
adult myoblasts derived from the Mstn
 /  muscle fibers
Figure 5. myostatin-null adult myoblasts 
proliferate faster than the wild-type 
myoblasts. Adult myoblasts were 
isolated from hind limbs of C57BL/10 
(Mstn
 / ) or myostatin-null mice (Mstn
 / ) 
and seeded at a low number. Proliferation 
rate determined for the myoblasts isolated 
from E17 (A) and 4-wk-old muscle (B). In 
addition, the proliferation rate determined 
for m. tibialis anterior (C) and m. soleus 
(D) muscle fiber–specific adult myoblasts 
is also shown. Experiments were done in 
triplicate. Data shown are an average of 
three animals. *, P   0.05; **, P   0.01 
(as compared with wild type). To 
determine the direct effect of Myostatin 
on satellite cell proliferation, adult 
myoblasts were isolated from wild-type 
and myostatin-null mice. Exogenous 
Myostatin was added to the proliferating 
myostatin-null myoblast cultures. As the 
concentration increased, the enhanced 
proliferative potential of the myostatin-
null myoblast decreased to that of the 
wild type (E).T
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have deregulated S phase entry, we next evaluated the ability
of Mstn
 /  myoblasts to withdraw from the cell cycle upon
mitogen withdrawal. Adult myoblasts derived from both
wild-type and myostatin knockout mice were switched to dif-
ferentiation low serum medium and pulsed with BrdU to
identify the total number of myoblasts that are still cycling
through the cell cycle in differentiation medium (DM). As
shown in Fig. 7 A, nearly 100% of cells incorporated BrdU
when the myoblasts were in GM. The majority of wild-type
myoblasts (67%) stopped proliferating and withdrew from
the cell cycle at 6 h after switching to DM. However, at this
time point, 50% of Mstn
 /  myoblasts were still in S phase,
indicating that these cells were still cycling through the S
phase and thus had not withdrawn to the G0 stage to differ-
entiate. Even at the 12-h time point, significantly more
Mstn
 /  myoblasts were in S phase as compared with wild-
type myoblasts (Fig. 7 A). Although delayed, eventually, the
majority of Mstn
 /  myoblasts do withdraw from the cell
cycle and differentiate within 48 h.
The myoblast cell cycle withdrawal process is temporally
regulated by the up-regulation of several cell cycle–specific
genes and myogenic differentiation markers. To establish
the molecular basis for this delayed differentiation of Mstn
 / 
cells, we performed expression analysis of differentiation-
specific genes such as MyoD and Myogenin. For this pur-
pose, adult myoblasts isolated from wild-type and myostatin
knockout mice were switched to DM, and protein extracts
were made from differentiating myoblasts at 0 (majority qui-
escent), 6, 12, 24, 48, and 72 h after switching to the low se-
rum media. The levels of differentiation-specific genes were
quantified by Western and densitometric analysis. As ex-
pected, MyoD protein levels peak immediately after switch-
ing to the DM (within 6 h) in both wild-type and myostatin
knockout myoblasts. However, in the myostatin-null myo-
blasts, the peak levels of MyoD continue until 12 h and then
slowly decline to basal levels at  48 h after switching to
DM (Fig. 7 B). Whereas in the wild-type myoblasts, a sharp
decline in the levels of MyoD was observed at 12 h of differ-
entiation. Similar to MyoD, the levels of the early differenti-
ation marker Myogenin peak within 6 h into differentiation
in wild-type myoblasts. However, in the Myostatin-deficient
myoblasts, the peak expression of Myogenin is delayed and
is seen at 24 h into differentiation (Fig. 7 C).
Discussion
Investigations into the molecular basis of Myostatin func-
tion revealed that Myostatin functions by controlling the
myoblast number during embryonic myogenesis (Thomas et
al., 2000). Several lines of evidence, including the expression
of Myostatin in postnatal muscle (Sharma et al., 1999), in-
creased postnatal muscle growth in myostatin-null mice
(McPherron et al., 1997), and expression of Myostatin in
nascent myotubes after muscle regeneration (Kirk et al.,
2000), compelled us to evaluate the role of Myostatin in
adult myogenesis. The results presented here clearly demon-
strate that Myostatin is expressed in satellite cells and that
Myostatin regulates satellite cell quiescence and self-renewal.
Before delineating the role of Myostatin in adult myogen-
esis, we attempted to demonstrate the expression of myosta-
tin mRNA and protein specifically in satellite cells, which
are the precursors of adult muscle. Immunocytochemistry
with anti-Myostatin antibodies on muscle transverse sec-
tions revealed intense Myostatin immunoreactivity in cells
that are juxtaposed to the surface of muscle fibers. Further,
immunostaining with antibodies against Pax7 (satellite cell
marker) on serial sections established that the cells positive
for Myostatin immunoreactivity are indeed the satellite cells
(Seale et al., 2000) (Fig. 1, A and B). Myostatin expression
Figure 6. Lack of Myostatin results in deregulated S phase entry 
of adult myoblasts. (A) Freshly isolated adult myoblasts were 
stained with propidium iodide and analyzed on a flow cytometer. 
10,000 cells of each genotype were analyzed on FACS
® and were 
distributed into the phases of the cell cycle based on the DNA 
content. Percentage of myostatin-null (Mstn
 / ) and wild-type 
(Mstn
 / ) myoblasts in S phase are shown in panel A. (B) Isolated 
myoblasts were synchronized to G1 phase, and once released into S 
phase, they were BrdU labeled and the percentage of BrdU-positive 
cells was counted at various time points. myostatin-null cells 
progress into the S phase more rapidly as compared with wild-type 
myoblasts. **, P   0.01. At least a total of 1,000 cells were counted 
in each of three replicates. Data presented are an average of three 
animals. (C) Western blot showing the levels of p21 and Cdk2 
protein in primary myoblasts cultured with ( ) or without ( ) 
Myostatin for 24 h. p21 protein was detected using anti-p21 
antibodies, and Cdk2 protein was detected using Cdk2 antibody. 
Tubulin protein levels are included to show equal loading.T
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was further confirmed in Pax7-positive satellite cells by in
situ hybridization (Fig. 1, C and D). In addition, purified
satellite cells appear to express myostatin mRNA and pro-
tein, confirming that Myostatin is present in satellite cells.
These results thus are in agreement with an earlier report,
where Cornelison et al. (2000) have shown the presence of
myostatin mRNA in the total RNA isolated from the single
satellite cell attached to the fiber. In the same study, they
also showed that, on activation of satellite cells, the levels of
Myostatin (GDF-8) were significantly down-regulated, sug-
gesting that high levels of Myostatin might be involved in
satellite cell quiescence.
Three independent techniques, RT-PCR, Western blot-
ting, and immunocytochemistry, were used to ascertain the
expression of myostatin in adult myoblasts. As shown in Fig.
3 A, the PCR reaction amplified the expected size fragment
of 1.2-kb myostatin ORF. In addition, anti-Myostatin anti-
bodies specifically recognized Myostatin on the Western
blot performed on the protein extracts derived from the
adult myoblasts (Fig. 3 B). To demonstrate the expression of
myostatin  in actively proliferating cells, primary cultures
were immunostained with Myostatin antibodies. As shown
in Fig. 3 C, virtually all the cultured myoblasts showed
staining with Myostatin antibodies and did not detect Myo-
statin in myoblasts isolated from myostatin knockout mice.
Thus, it is clear from these results that Myostatin is ex-
pressed in satellite cells and in the adult myoblasts derived
from satellite cells.
If Myostatin negatively regulates the activation of satellite
cells, we reasoned that in myostatin knockout mice there
would be increased activation of satellite cells. Consistent
with this hypothesis, a BrdU labeling experiment showed
that in myostatin knockout animals, there is a significant in-
crease in the pool of activated satellite cells as compared with
wild-type mice. Although there is a significant reduction in
the pool of activated satellite cells with age, myostatin-null
muscle fibers exhibit considerably more activated satellite
cells even at 6 mo (Fig. 4 A, i), which is consistent with the
Figure 7. Delayed cell cycle with-
drawal and differentiation of myostatin-
null adult myoblasts. Isolated myoblasts 
from C57BL/10 (Mstn
 / ) or myostatin-
null mice (Mstn
 / ) were switched to 
DM, and the cells were pulsed with 
BrdU before fixing at 0-, 6-, 12-, 24-, or 
48-h time points. Percentage of cells that 
incorporate BrdU are shown for every 
time point in panel A. *, P   0.05; **,
P   0.01 (as compared with wild type). 
Over 1,000 cells were counted in each 
of three replicates. The data presented 
are an average of three animals (A). 
Freshly isolated myoblasts from C57BL/
10 (WT) or myostatin-null mice (KO) 
were switched to DM, and proteins were 
extracted at indicated time points. Time 
0 indicates freshly isolated quiescent 
satellite cells. Western analysis (n   3) 
with MyoD (B) and Myogenin (C) 
antibodies on protein extracts from 
differentiating myoblasts is shown. 
Maximum expression was termed 
100%, and relative expression at various 
time points was plotted. Anti– -tubulin 
Western indicates equal loading.T
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persistent postnatal muscle growth and lack of muscle wast-
ing observed in myostatin-null mice (McPherron and Lee,
2002). Recently, the breeding of the myostatin-null mouse
with the mdx mouse resulted in the amelioration of the
symptoms (Wagner et al., 2002). Also, the injection of a
specific antibody to Myostatin into the mdx mice alleviated
the severity of the phenotype; in fact, the mice gained mus-
cle mass and increased the production of the muscle protein
creatine kinase, indicating improvement of muscle strength
(Bogdanovich et al., 2002). Whittemore et al. (2003) also
injected inhibitory Myostatin antibody into wild-type mice
and demonstrated increased skeletal muscle mass and in-
creased grip strength. These results further indicate that Myo-
statin acts postnatally as a negative regulator of satellite cell
activation and skeletal muscle growth. In addition to the in-
creased muscle growth through hyperplasia, myostatin-null
mutant mice also display hypertrophy, which has been re-
lated to increased satellite cell activity. One explanation for
the increased number of myonuclei, and thus hypertrophy
of myostatin-null muscle fiber, is the observed spontaneous
activation of satellite cells in the absence of Myostatin. Con-
verse to this, the addition of Myostatin to isolated myofibers
decreased the activation of satellite cells, when normally they
would be induced to activate (Fig. 4 A, ii).
For activation, it is essential that the quiescent satellite
cells either in G0 or G1 should reenter the S phase to un-
dergo cell cycle progression. Hence, negative regulators of
satellite cell activation, such as Myostatin, could possibly
regulate satellite cell activation by controlling the G1 to S
phase transition. Indeed, the results from this study (Fig. 6
C) suggest that high levels of Myostatin can inhibit G1 to S
progression of the cell cycle by down-regulating Cdk2 and
up-regulating p21, which would result in hypophosphoryla-
tion of pRB. Hence, it is quite possible that the higher levels
of Myostatin observed in quiescent satellite cells (Cornelison
et al., 2000) maintain the G0 status by regulating the G1/S
check point. In the myostatin knockout mice, we also ob-
served an increase in the number of CD34-positive satellite
cells per unit length of fiber as compared with wild-type
mice (Fig. 4 B, i). A recent report suggested that in order to
meet the demand and maintain a constant pool of satellite
cells on muscle fibers, satellite cells must self-renew like stem
cells. The self-renewal process is accomplished by returning
a pool of satellite cell–derived myoblasts to the quiescent sta-
tus on muscle fibers (Seale and Rudnicki, 2000). An in-
creased number of satellite cells per unit fiber thus means
that in the absence of Myostatin, there is increased self-
renewal of satellite cells, possibly by increased proliferation
of satellite cell–derived myoblasts. This theory is supported
by the observation that the adult myoblasts derived from the
satellite cells of myostatin knockout mice appear to have a
shorter doubling time and proliferate much faster as com-
pared with the wild-type adult myoblasts (Fig. 5). This in-
creased proliferation rate of Mstn
 /  adult myoblasts could
result in increased self-renewal and thus elevate the number
of satellite cells per unit fiber. On the contrary, the addition
of exogenous Myostatin to myostatin-null myoblasts de-
creases their proliferation rate to that of wild type (Fig. 5 E).
This increased proliferation of myostatin-null myoblasts
can be attributed to a deregulated G1 to S transition. The
use of FACS
® and BrdU uptake demonstrated that this was
indeed the case. Two to three times more myostatin-null myo-
blasts were in the S phase of the cell cycle at any one time
(Fig. 6 A). Furthermore, after synchronizing myostatin-null
or wild-type myoblasts, more myostatin-null cells entered
into the S phase (Fig. 6 B).
Myoblast differentiation is a highly orchestrated step
wherein the withdrawal of myoblasts from the cell cycle to
G0 should occur before the committed myoblasts postmitot-
ically differentiate into myotubes. Molecular analysis indi-
cates that low mitogen medium triggers the up-regulation of
MyoD, which in turn induces the expression of the p21
gene. Concomitant up-regulation of p21 and decrease of G1
cyclins and Cdks results in the withdrawal of myoblasts to
G0 and terminal differentiation. Thus, the rate of with-
drawal of myoblasts is an important step in the differentia-
tion of myoblasts into myotubes. The studies with BrdU
labeling clearly indicated that the wild-type myoblasts im-
mediately withdraw from the cell cycle, whereas, the myosta-
tin-null myoblasts appear to undergo the cell cycle longer,
Figure 8. A model for the role of Myostatin in postnatal muscle 
growth. Quiescent satellite cells on muscle fibers are activated in 
response to muscle injury to give rise to myoblasts. Proliferating 
myoblasts can either fuse with the existing fiber or differentiate into 
a nascent myotube. A portion of proliferating myoblasts, however, 
can revert to become quiescent satellite cells, thus resulting in 
self-renewal. As Myostatin is a negative regulator of cell cycle 
progression, high levels of Myostatin in satellite cells block the 
activation to maintain quiescence.T
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resulting in delayed withdrawal from the cell cycle (Fig. 7
A). The molecular basis for delayed withdrawal appears to be
prolonged expression of MyoD and delayed peak expression
of a differentiation-specific marker, such as Myogenin, in
myostatin-null myoblasts (Fig. 7, B and C). These results
certainly point out that Myostatin, by regulating MyoD ex-
pression, plays a key role in adult myoblast differentiation.
Immunostaining with Myosin heavy chain antibody (un-
published data) and gene expression analysis revealed that
loss of Myostatin results in delayed withdrawal from the cell
cycle and differentiation of primary myoblasts derived from
satellite cells. Consistent with this hypothesis, Rios et al.
(2002) and Langley et al. (2002) very recently demonstrated
that excess Myostatin in DM blocks the differentiation of
C2C12 myoblasts by inhibiting MyoD expression. Eventu-
ally, however, the Myostatin-deficient myoblasts do differ-
entiate, albeit delayed.
In conclusion, we propose that Myostatin blocks the acti-
vation of satellite cells and also negatively regulates self-
renewal of satellite cells (Fig. 8). Increased activation of
Mstn
 /  satellite cells, and subsequent enhanced prolifera-
tion with delayed differentiation of myostatin-null myo-
blasts, could thus be the primary reason for the increased
postnatal muscle growth and hypertrophy in myostatin-null
animals. To our knowledge, this is the first report of a se-
creted growth factor that is expressed in satellite cells and
maintains the satellite cell quiescence.
Materials and methods
Animals
myostatin-null mice (C57BL/10 background) were obtained from S.-J. Lee
(The Johns Hopkins University, Baltimore, MD). Wild-type mouse strain
C57BL/10 was bred at the Ruakura Small Animal Colony.
BrdU labeling of satellite cells in vivo
To determine the activated satellite cells in vivo at a given time point,
BrdU labeling was used. Three C57BL/10 or Mstn
 /  mice at ages 4 wk, 8
wk, or 6 mo were intraperitoneally injected with BrdU (30 mg/kg) as a sin-
gle pulse 2 h before killing. Satellite cells from m. tibialis anterior were iso-
lated using Percoll gradient as per the published protocol (Allen et al.,
1997; Partridge, 1997; Yablonka-Reuveni et al., 1999). To detect activated
satellite cells, 5,000–10,000 satellite cells were fixed using 0.25% glutaral-
dehyde and immunostained for BrdU using the cell proliferation kit (Amer-
sham Biosciences). A minimum of 1,000 immunostained satellite cells
were counted to calculate the percentage of BrdU-positive cells.
Determination of satellite cell number on muscle fiber
M. tibialis anterior was excised from six C57BL/10 or Mstn
 /  mice, and
individual muscle fibers were isolated by the method of Rosenblatt et al.
(1995). Isolated fibers were fixed in an eight-well Lab-Tek chamber slide
(Nunc) with 0.25% glutaraldehyde for 1 min and rinsed with PBS for im-
munocytochemistry. Satellite cell detection with CD34 antibodies (Santa
Cruz Biotechnology, Inc.) and counting were performed according to the
method of Beauchamp et al. (2000). The total number of migrated satellite
cells was counted after 72 h incubation of the wild-type and myostatin-
null tibialis anterior muscle fibers in fiber medium (FM) at 37 C, 5% CO2.
Effect of Myostatin on satellite cell migration
To determine the effect of Myostatin on the migration of satellite cells from
the fiber, isolated muscle fibers were either placed in FM or in FM with ti-
trating amounts of Myostatin for 96 h at 37 C, 5% CO2. Wells were ana-
lyzed for satellite cell migration, and satellite cells were counted. Repli-
cates of at least 24 fibers were used for statistical analysis.
Cell cycle analysis of adult myoblasts
Adult myoblasts were cultured according to the published methods (Allen
et al., 1997; Partridge, 1997; Yablonka-Reuveni et al., 1999). FACS
® anal-
ysis of primary myoblasts was done according to the method of Thomas et
al. (2000). To monitor the cell cycle progression, adult myoblasts were
synchronized at the G1/S boundary and released to S phase by the method
of Kitzmann et al. (1998). The myoblasts in S phase were pulsed with 0.1
mM BrdU for 15 min, fixed, and processed for immunocytochemistry. To
determine the cell cycle withdrawal of adult myoblasts, proliferating adult
myoblasts were switched to DM and pulsed with 0.1 mM BrdU at 0-, 6-,
12-, 24-, or 48-h time points. The myoblasts were fixed and immuno-
stained for BrdU.
Myoblast proliferation assay
Primary myoblasts were cultured from hind limb muscles of three 4-wk-old
mice or six to eight E17 mouse embryos according to the published proto-
cols (Allen et al., 1997; Partridge, 1997; Yablonka-Reuveni et al., 1999).
Embryonic primary myoblasts and satellite cells isolated from fast or slow
fibers were seeded at low density of  100 cells/cm
2 in GM, and cells were
counted every 24 h. Adult myoblasts were cultured as described earlier
and were seeded at a density of 6,097 cells/cm
2 in GM on Matrigel-coated
96-well microtitre plates. Cell counting and methylene blue photometric
endpoint assay were performed according to the published protocols (Ol-
iver et al., 1989; Chakravarthy et al., 2000).
To demonstrate the direct effect of Myostatin on myoblast proliferation,
myoblasts were isolated from myostatin-null and wild-type skeletal mus-
cle. Isolated myoblasts were seeded at a density of 6,097 cells/cm
2 in GM
on Matrigel-coated 96-well microtitre plates. Exogenous Myostatin was
added in increasing concentrations (n   8 per concentration) to myostatin-
null myoblasts, and 48 h later, cell number was assessed using the methy-
lene blue assay according to the published protocols (Oliver et al., 1989;
Chakravarthy et al., 2000).
In situ hybridization
M. tibialis anterior muscle tissue was fixed in 4% paraformaldehyde (wt/
vol) in PBS for 16 h at room temperature, washed, dehydrated through an
ascending ethanol series, and embedded in paraffin wax. Sections were
then cut at 7  m and mounted on microscope slides (SuperfrostPlus; Fisher
Scientific). For the generation of digoxigenin probes, a 326-bp fragment of
the mature myostatin cDNA (bp 905–1231; Genbank/EMBL/DDBJ acces-
sion no. NM_010834.1) or a 571-bp fragment of the Pax7 cDNA (bp 963–
1534; Genbank/EMBL/DDBJ accession no. XM_131758.2) were cloned
into the pGEM-T easy vector and transcribed according to the manufac-
turer’s recommendation (DIG RNA Labeling Kit; SP6/T7; Boehringer). Par-
affin-embedded sections were dewaxed, and in situ hybridizations were
performed according to the method of Greiwe et al. (2001).
Immunocytochemistry
M. tibialis anterior muscle tissue was removed from C57BL/10 or Mstn
 / 
mice, fixed, and sectioned according to the method of Sharma et al.
(1999). The sections were incubated with either 1:50 diluted Myostatin
polyclonal antibody (Sharma et al., 1999) or with 1:100 diluted Pax7
mouse monoclonal antibody (DSHB). Subsequent steps of immunostaining
were performed according to the published protocol (Thomas et al., 2000).
Primary cultures fixed with 0.25% glutaraldehyde on eight-well Lab-Tek
chamber slides were permeabilized with 0.1% Triton X-100 in PBS at
room temperature, and the immunocytochemistry was performed accord-
ing to the method of Beauchamp et al. (2000). Detailed procedures are
available on request. Photographs were taken using an Olympus BX50
microscope (Olympus) fitted with a DAGE-MTI DC-330 color camera
(DAGE-MTI, Inc.).
Western blotting
Adult myoblasts were extracted from C57BL/10 or myostatin-null muscle
tissue as described above. Percoll gradient–enriched quiescent satellite
cells, proliferating myoblasts, or myoblasts changed to DM (DME, 2% [vol/
vol] HS) for 0, 6, 12, 24 or 48 h were resuspended in 200  l of protein ly-
sis solution (50 mM Tris, pH 7.6, 250 mM NaCl, 5 mM EDTA, 0.1% Noni-
det P-40; Complete™ protease inhibitor; Boehringer). The suspension was
passed through a fine syringe needle to lyse the cells. Protein was mea-
sured using protein assay reagent (Bio-Rad Laboratories). Proteins (10  g)
were separated on SDS-PAGE (4–12% gradient; Novex) and then trans-
ferred to a nitrocellulose membrane. Western blots for MyoD and Myoge-
nin were performed according to the protocol described previously
(Thomas et al., 2000). Western blots for Myostatin were performed as de-
scribed by Sharma et al. (1999). To detect the changes in the levels of p21
and Cdk2 upon Myostatin treatment, Western blotting was performed.
Adult myoblasts were treated with 10  g/ml Myostatin for 24 h, and the
protein extracts from the myoblasts were made as described above. TheT
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Western analysis for p21 and Cdk2 was performed according to Thomas et
al. (2000). Western blot of  -tubulin was performed to show equal protein
loading.
Detection of Myostatin in fiber-dissociated satellite cells and 
adult myoblasts
Satellite cells and adult myoblasts were isolated from 6-wk-old mice using
the Percoll gradient method (Goodell et al., 1996). Total RNA was isolated
by using TRIZOL reagent (Invitrogen) according to the manufacturer’s pro-
tocol, and RT-PCR was performed to amplify myostatin as described previ-
ously (Kambadur et al., 1997). Pax7 cDNA was PCR amplified using 5 -
GCTGCCGGACTCTACCTACC-3  and 5 -CCAGCACAGCGGAGTGTTCC-
3  primers and the following conditions: 95 C for 15 s, 55 C for 30 s, and
72 C for 30 s for 35 cycles. CD34 was PCR amplified using a published
protocol (Beauchamp et al., 2000). Protein extracts from satellite cells
were made as described above, and Western blot for Myostatin was per-
formed according to the published method (Sharma et al., 1999).
Statistical analysis
To determine the significance between two groups, comparisons were
made using a t test. The data are presented as means   SEM.
The Pax 7 monoclonal antibody developed by Atsushi Kawakami was ob-
tained from the Developmental Studies Hybridoma Bank developed under
the auspices of the National Institute of Child Health and Human Develop-
ment and maintained by The University of Iowa Department of Biological
Sciences. We would like to thank Dr. S.J Lee for the donation of myostatin-
null mice. The authors would like to thank Dr. John Bass and Brett Langley
for critically reading the manuscript. We thank Alex Hennebry for techni-
cal help.
We are indebted to the Foundation for Research, Science, and Technol-
ogy (New Zealand) and Royal Society of New Zealand (Marsden Fund) for
financial support.
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